Buy Catabasis Pharmaceuticals Stock | CATB Stock Price & Latest News | Public
CATB

Catabasis Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap

    About CATB

    Catabasis Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is edasalonexent, which is intended for the treatment of Duchenne muscular dystrophy. The company was founded by Michael R. Jir...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.19
    -0.37
    -0.56
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.37

    Actual EPS
    Q4 2020

    Stats

    Market Cap$32,73M
    Volume6,17M
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$8.59
    1 Year Low$1.25
    Open$1.83
    High$3.25
    Low$1.76

    Buy any stock with any amount of money.

    Download the App
    Download the app